healthcare
healthcare on World Data Ocean: a running collection of 3 stories we have gathered and hand-picked because they are worth your time. Every post here touches on healthcare in some way — the news, the analysis, the deep dives, and the occasional surprise find. A Global Hub for Ocean Intelligence 4 World Data Ocean is a centralized digital platform where researchers, scientists, and ocean enthusiasts converge to explore, analyze, and… New stories are added to this page as we find them, so check back if you want to keep up with what is happening around healthcare, or subscribe to the RSS feed to get them as soon as they are published. Browse the collection below, or head back to the homepage to see everything World Data Ocean is covering right now.

An unproven autism drug got a boost after a White House briefing
In fall 2025, the Trump administration’s endorsement of leucovorin as an autism therapy sparked a significant increase in its prescription for children, despite a lack of newly validated evidence supporting its efficacy. This event underscores the potential impact of policy pronouncements on medical practices and public health. Our reporting emphasizes the critical need for empirical data to guide treatment decisions. For related advancements in medical innovation, see our article, "No refrigerator, no problem. This experimental vaccine doesn’t need it."

World’s Largest Civilian Hospital Ship Ghana’s Port Of Tema For A 10-Month Stay
The Global Mercy, the world’s largest civilian hospital ship, has arrived at Ghana’s Port of Tema for a ten-month deployment. Operated by Mercy Ships, this innovative platform delivers critical, specialized healthcare services to underserved communities. This extended stay represents a significant commitment to providing accessible medical care and fostering collaborative partnerships within Ghana and the wider region.

Here’s what the first mRNA flu vaccine could mean for flu season
Emerging data validate a significant advancement in influenza prevention: Moderna’s mFlusiva, the first mRNA flu vaccine, demonstrates superior efficacy compared to traditional flu shots. Clinical trials indicate stronger, longer-lasting immunity and improved protection against infection. This innovative approach represents a potential paradigm shift in seasonal influenza management, offering a more robust defense against prevalent strains. For further exploration of immunological advancements, see our related article, "How one amino acid might help fight colon cancer and infections."